These results for the first time illustrate the pivotal role of GIGYF2 in regulating PTEN-mediated inactivation of the PI3K/AKT pathway, leading to the development of IR and T2D in the context of obesity. This evidence concerns the gene GIGYF2 and type 2 diabetes mellitus.